ESTRO37_ProgrammeBook

INTERDISCIPLINARY PRE-MEETING COURSE

Combined SBRT and targeted-immune therapies: biological and clinical perspectives

FRIDAY 20 APRIL 2018 08:30-17:30 | ROOM 116 Course directors: Eric Lartigau (FR) and Ala Yaromina (NL)

Course aim To provide an overview of the current and potential future role of SBRT in combination with targeted and immunotherapies in translational research and clinical practice.

Learning objectives • To summarise radiobiological effects of high dose per fraction on tumour and normal tissues • To assess the clinical effectiveness of SBRT in different tumour sites • To identify the limitations of SBRT • To define the biological mechanisms for the rational combination of targeted and immune therapies with high dose fractions • To assess the clinical effectiveness of SBRT combined with systemic targeted /immune therapies in different tumour site including cancers of the lung, liver and gastrointestinal tract • To discuss with experts, future research and clinical implementation. Who should attend? Radiation oncologists, senior residents and radiobiologists who are interested in learning and improving their knowledge in combined SBRT and targeted immune therapies background, state-of-the-art and perspectives.

PROGRAMME | Programme and Exhibition Guide

50